期刊文献+

一种用于脂肪肝脂毒性药理研究的体外模型 被引量:7

An in vitro model applicable for fatty liver lipotoxicity pharmacological research
原文传递
导出
摘要 目的建立和复制一种适合大鼠药物血清进行脂肪肝脂毒性药理研究的体外模型。方法以大鼠血清替代胎牛血清培养HepG2细胞,添加长链游离脂肪酸(油酸1mmol/L、棕榈酸0.5mmol/L)刺激,观察上清液中肿瘤坏死因子(TNF)α含量、细胞内甘油三酯含量,细胞脂肪油红染色及电镜下观察超微结构变化;同时观察细胞TNFα蛋白及其基因表达,细胞组织蛋白酶B(ctsb)表达和分布的变化。结果游离脂肪酸刺激24h后,HepG2细胞内甘油三酯显著沉积,高达527.24mg/g(t=23.6,P〈0.01);上清液中TNFα含量显著升高,增至52.04pg/mg(t=2.6,P〈0.05);细胞ctsb、TNFα的蛋白表达及其mRNA表达均显著增强。结论在大鼠血清培养环境下,游离脂肪酸可通过对ctsb作用显著诱导HepG2细胞脂肪变性和TNFα分泌,方法简易经济,可作为一种较理想的抗脂肪肝脂毒性药理研究模型。 Objective To establish an in vitro model applicable for fatty liver lipotoxicity pharmacological research. Methods HepG2 cells were cultured with rat serum instead of fetal bovine serum and with long-chum free fatty acid (FFA) added. The tested radices were: the content of serum TNF α, cellular triglycerides (TG) content, Oil Red staining and ultrastructural changes; protein expression and gene expression of cellular TNF α, and the expression and distribution of cathepsin B (Ctsb). Results After incubation with FFA for 24 hours, the TG deposition of HepG2 in the model group increased markedly and TG content was 627.24 mg/g protein (t = 23.6, P 〈 0.01), TNF α content in the cell supematant also increased to 52.04 pg/mg protein (t = 2.6, P 〈 0.05). Compared with those of the normal group, the protein expression and mRNA expression of cellular TNF α and Ctsb also increased significantly. Conclusion FFA could induce a model of HepG2 steatosis with TNF α secretion through the Ctsb signal pathway using rat serum in the culture media. The method is simple and economical, which is an ideal model applicable for fatty liver lipotoxicity pharmaeologieal research.
出处 《中华肝脏病杂志》 CAS CSCD 北大核心 2008年第2期121-124,共4页 Chinese Journal of Hepatology
基金 国家自然科学基金(30672635).上海市优秀学科带头人计划项目(No.06XD14018) 上海市教委重点学科建设项目(Y0302)
关键词 游离脂肪酸类 甘油三酯类 肿瘤坏死因子Α 模型 动物 Free fatty acids Triglycerides Tumor necrosis factor-alpha Model, animal
  • 相关文献

参考文献8

  • 1Feldstein AE, Werneburg NW, Canbay A, et al. Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway. Hepatology, 2004, 40:185-194.
  • 2Heider JG, Boyett RL. The picomole determination of free and total cholesterol in cells in culture. J Lipid Res, 1978, 19: 514-517.
  • 3曾民德.葡萄糖毒性、脂肪毒性与非酒精性脂肪性肝病[J].中华肝脏病杂志,2005,13(2):81-82. 被引量:64
  • 4Unger RH. The physiology of cellular liporegulation. Annu Rev Physiol, 2003, 65: 333-347.
  • 5Boden G, Cheung P, Slein TP, el al. FFA cause hepatic insulin resistance by inhibiting insulin suppression of glycogenolsis. Am J physiol Endoerinol Metab, 2002, 283: E12-9.
  • 6Liu H, Jones BE, Bradham C, et al. Increased cytochrome P-450 2E1 expression sensitizes hepatocytes to c-Jun-mediated cell death from TNF-alpha. Am J Physiol Gastrointest Liver Physiol, 2002. 282: G257-G266.
  • 7Wemeburg N, Guicciardi ME, Ym XM, ct al. TNF-alpha-mediated lysosomal permeabilization is FAN and caspase 8/Bid dependent. Am J Physiol Gastrointest Liver Physol, 2004, 287: G436-443.
  • 8Guicciardi ME, Miyoshi tt, Bronk SF, et al. Cathepsin B knockout mice are resistant to tumor necrosis factor-alpha-mediated hepatocyte apoptosis and liver injury: implications for therapeutic applications. Am J Pathol, 2001, 159: 2045-2054.

二级参考文献13

  • 1Sorrentino P, Tarantino G, Conca P, et al. Silent non-alcoholic fatty liver disease: a clinical histological study. J Hepatol, 2004,41:751-757.
  • 2Seidell JC. Obesity, insulin resistance and diabetes-a world wide epidemic. Br J Nutr, 2000, 83(Suppl 1): S5-8.
  • 3Jansen PL. Non-alcoholic steatohepatitis. Eur J Gastroenterol Hepatol, 2004, 16: 1079-1085.
  • 4Omagari K, Kadokawa Y, Masuda J, et al. Fatty liver in non-alcoholic non-overweight Japanese adults: incidence and clinical characteristics. Gastroenterol Hepatol, 2002, 17: 1098-1105.
  • 5Choudhury J, Sanyal AJ. Insulin resistance and the pathogenesis of nonalcoholic fatty liver disease. Clin liver Dis, 2004, 8: 575-594.
  • 6Day CP. The potential role of gene in nonalcoholic fatty liver disease. Clin liver Dis, 2004, 8: 673-691.
  • 7Bradbury MW, Berk PD. Lipid metabolism in hepatic steatosis. Clin liver Dis, 2004, 8: 639-671.
  • 8Feldstein A, Gores GJ. Steatohepatitis and apoptosis: therapeutic implications. Am J Gastroenterol, 2004, 99: 1718-1719.
  • 9Pessayre D, Fromenty B, Mansouri A. Mitochondrial injury in steatohepatitis. Eur J Gastroenterol Hepatol, 2004, 16: 1095-1105.
  • 10Lopez-Bermejo A, Botas P, Funahashi T, et al. Adiponectin, hepatocellular dysfunction and insulin sensitivity. Clin Endocrinol, 2004,60: 256-263.

共引文献63

同被引文献51

引证文献7

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部